Cargando…

Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?

The SARS-CoV-2 pandemic has affected the daily life of the worldwide population since 2020. Links between the newly discovered viral infection and the pathogenesis of neurodegenerative diseases have been investigated in different studies. This review aims to summarize the literature concerning COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krey, Lea, Huber, Meret Koroni, Höglinger, Günter U., Wegner, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699589/ https://www.ncbi.nlm.nih.gov/pubmed/34942956 http://dx.doi.org/10.3390/brainsci11121654

Ejemplares similares

Patient Safety in a Box: Implementation and Evaluation of the Emergency Box in Geriatric and Parkinson Patients
por: Krey, Lea, et al.
Publicado: (2021)

Alexithymia Is Associated with Reduced Quality of Life and Increased Caregiver Burden in Parkinson’s Disease
por: Klietz, Martin, et al.
Publicado: (2020)

Validation of the Parkinson's Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy
por: Klietz, Martin, et al.
Publicado: (2021)

Neuropsychiatric Symptoms in Parkinson’s Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden
por: von Eichel, Hannah, et al.
Publicado: (2022)

Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient
por: Huber, Meret, et al.
Publicado: (2020)

Relationship Satisfaction in People with Parkinson’s Disease and Their Caregivers: A Cross-Sectional Observational Study
por: Heine, Johanne, et al.
Publicado: (2021)

Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
por: Huber, Meret K., et al.
Publicado: (2021)

Analysis of Parkinson’s Disease Outpatient Counselling for Advance Directive Creation: A Cross-Sectional Questionnaire-Based Survey of German General Practitioners and Neurologists
por: Jensen, Ida, et al.
Publicado: (2022)

Case report: Early-onset Parkinson's disease with initial spastic paraparesis and hyperreflexia caused by compound heterozygous PRKN-gene exon 2 and 4 deletions
por: Jensen, Ida, et al.
Publicado: (2022)

One Year Trajectory of Caregiver Burden in Parkinson’s Disease and Analysis of Gender-Specific Aspects
por: Klietz, Martin, et al.
Publicado: (2021)

Analysis of Transition of Patients with Parkinson’s Disease into Institutional Care: A Retrospective Pilot Study
por: Jensen, Ida, et al.
Publicado: (2021)

Consensus-Based Recommendations for Advance Directives of People with Parkinson’s Disease in Regard to Typical Complications by German Movement Disorder Specialists
por: Klietz, Martin, et al.
Publicado: (2020)

SARS-CoV-2, COVID-19 and Neurodegeneration
por: Tönges, Lars, et al.
Publicado: (2022)

Mindfulness and Psychological Flexibility are Inversely Associated with Caregiver Burden in Parkinson’s Disease
por: Klietz, Martin, et al.
Publicado: (2020)

Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration
por: Dolatshahi, Mahsa, et al.
Publicado: (2021)

Cerebral Microstructural Alterations in Patients With Early Parkinson’s Disease Detected With Quantitative Magnetic Resonance Measurements
por: Klietz, Martin, et al.
Publicado: (2021)

Correction to: Pathophysiological Clues to how the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration
por: Dolatshahi, Mahsa, et al.
Publicado: (2021)

SARS-CoV-2, long COVID, prion disease and neurodegeneration
por: Zhao, Yuhai, et al.
Publicado: (2022)

SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
por: Zhao, Yuhai, et al.
Publicado: (2022)

SARS‐CoV‐2, aging, and Post‐COVID‐19 neurodegeneration
por: Strong, Michael J.
Publicado: (2022)

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

Sowing SARS-CoV-2 to reap neurodegeneration: A hamster study
por: Rasika, S., et al.
Publicado: (2022)

Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?
por: Juric, Ivana, et al.
Publicado: (2021)

Atypical pantothenate kinase-associated neurodegeneration with variable phenotypes in an Egyptian family
por: Shalash, Ali S., et al.
Publicado: (2021)

SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration
por: Idrees, Danish, et al.
Publicado: (2021)

Can exposure to heat attenuate neurodegeneration in older adults with Parkinson's disease?
por: Clark, Cayla E., et al.
Publicado: (2023)

Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Scorza, Fulvio A., et al.
Publicado: (2021)

SARS-CoV-2 Infection Leads to Neurological Dysfunction
por: Acharya, Arpan, et al.
Publicado: (2020)

Phytochemicals against SARS-CoV as potential drug leads
por: Swain, Shasank Sekhar, et al.
Publicado: (2021)

Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration?
por: Young, Michael J., et al.
Publicado: (2020)

SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies
por: Putilina, M. V., et al.
Publicado: (2021)

A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease
por: Rieder, Alessandra S., et al.
Publicado: (2022)

SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability
por: Foster, Charles S.P., et al.
Publicado: (2022)

SARS-CoV-2-Specific Antibody Prevalence and Symptoms in a Local Austrian Population
por: Ladage, Dennis, et al.
Publicado: (2021)

SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy
por: Merello, Marcelo, et al.
Publicado: (2021)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

SARS-CoV-2 dysregulation of PTBP1 and YWHAE/Z gene expression: A primer of neurodegeneration
por: Vavougios, George D.
Publicado: (2020)

Can SARS-CoV-2 trigger reactive arthritis?
por: Wendling, Daniel, et al.
Publicado: (2021)

Human antibodies can neutralize SARS-CoV-2
por: Catalan-Dibene, Jovani
Publicado: (2020)

Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
por: Dechaumes, Arthur, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_brrjutdcg0tr5jffkeup99l1rk